Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function.

about

Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function.

Item

http://www.wikidata.org/entity/Q42733150

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Changes in Weight and Glucose ...... provements in β-Cell Function.

@en

Changes in Weight and Glucose ...... provements in β-Cell Function.

@nl

type

Item

label

Changes in Weight and Glucose ...... provements in β-Cell Function.

@en

Changes in Weight and Glucose ...... provements in β-Cell Function.

@nl

prefLabel

Changes in Weight and Glucose ...... provements in β-Cell Function.

@en

Changes in Weight and Glucose ...... provements in β-Cell Function.

@nl

P1476

Changes in Weight and Glucose ...... provements in β-Cell Function.

@en

P2093

K J Mather

http://www.w3.org/2001/XMLSchema#string

M S Kirkman

http://www.w3.org/2001/XMLSchema#string

R V Considine

http://www.w3.org/2001/XMLSchema#string

T S Hannon

http://www.w3.org/2001/XMLSchema#string

Y R Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Progression from newly acquired impaired fasting glusose to type 2 diabetes

Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4

Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI: data from the DESIR study.

Defining and characterizing the progression of type 2 diabetes.

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

P304

4076-4084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2016-2056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27533307

http://www.w3.org/2001/XMLSchema#string

P932

5095260

http://www.w3.org/2001/XMLSchema#string